CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM NEW
Total 13F shares
4,422,003
Share change
+240,965
Total reported value
$36,260,000
Price per share
$8.20
Number of holders
21
Value change
+$1,984,832
Number of buys
10
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q4 2017

As of 31 Dec 2017, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,422,003 shares. The largest 10 holders included ACUTA CAPITAL PARTNERS, LLC, WELLINGTON MANAGEMENT GROUP LLP, ARS Investment Partners, LLC, Vanguard Group Inc, ROYCE & ASSOCIATES LP, BRIDGEWAY CAPITAL MANAGEMENT INC, WELLS FARGO & COMPANY/MN, Benchmark Capital Advisors, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc.. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.